Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by retiredcop

PMN

Biogen losing traction

 For Biogen’s ill-fated Alzheimer’s disease drug Aduhelm, a narrow...

June 23, 2022

PMN

Trading blackout lifted

Announcement made that company pursuing listing on Nasdaq and suddenly...

June 23, 2022

PMN

CRENEZUMAB UPDATE

https://www.alzforum.org/news/research-news/api-colombian-trial-crenezumab...

June 20, 2022

PMN

PARKINSONS TRIAL

 Clinical trial suggests Parkinson's drug is safe in humans https...

June 14, 2022

PMN

RE:RE:RE:RE:RE:RE:RE:The Big IF

https://www.canada.ca/en/health-canada/services/drugs-health-products...

June 4, 2022

PMN

RE:Biogen update

https://www.fiercepharma.com/marketing/neurologists-turning-their-backs...

May 17, 2022

PMN

Biogen update

  11 May 2022 Last months' decision by the U.S. Centers for...

May 16, 2022

PMN

RE:RE:RE:Leede Jones Gable starts ProMIS at speculative buy; PT 50

LJG has one very important short-term goal ..they have made it public that...

May 16, 2022

PMN

RE:New Facebook post from Eugene Williams

 Contributing means partnerships which means more opportunities ...can...

May 12, 2022

PMN

due process

Primates are needed to test certain drugs with potential effects on female...

May 3, 2022

PMN

RE:RE:Biogen CEO Resigns!!

Biogen is double-dipping into a 2020 collaboration with Scribe Therapeutics...

May 3, 2022

PMN

RE:RE:560 Million Shares

All these complaining about the executives and board members yet when we have...

April 30, 2022

PMN

RE:RE:RE:RE:RE:Biogen update

We might have a situation where our PMBN310 clinicals will be conducted in...

April 25, 2022

PMN

RE:RE:RE:RE:Biogen update

https://theconversation.com/the-fda-approved-a-new-drug-to-treat-alzheimers...

April 15, 2022

PMN

Als treatment discontinued for now

Based on data from a Phase 1 clinical trial, Biogen and Ionis...

April 12, 2022

PMN

RE:RE:RE:Biogen update

Not sure if anyone else picked up on what was said in this last article. ...

April 8, 2022

PMN

RE:RE:Biogen update

CNN)Medicare will restrict coverage of the controversial and costly...

April 8, 2022

PMN

RE:Biogen update

Bad news for Biogen: Medicare didn't change its mind.   ...

April 8, 2022

PMN

RE:RE:RE:RE:Prothena

https://www.alzforum.org/news/conference-coverage/scientists-re-analyze...

April 4, 2022

PMN

RE:RE:Why is the PR still at 0.13 when there are so many PR's

Does not a "blackout for trading on the board"  become insider...

March 23, 2022

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Biosenta Inc.

Biosenta Inc. C.ZRO

Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and ... view more »